...
首页> 外文期刊>Der Pharmacia Lettre >3D-QSAR and molecular docking studies of quinazoline derivatives as glycogen synthase kinase-3?2 (Gsk-3?2) inhibitors
【24h】

3D-QSAR and molecular docking studies of quinazoline derivatives as glycogen synthase kinase-3?2 (Gsk-3?2) inhibitors

机译:喹唑啉衍生物作为糖原合酶激酶3?2(Gsk-3?2)抑制剂的3D-QSAR和分子对接研究

获取原文
           

摘要

The discovery of glycogen synthase kinase-3β (GSK3β) inhibitors has proven to be challenging task to identify novel and potent gsk3β inhibitors. The quantitative structure activity relationship (QSAR) and docking approach became very useful and largely widespread technique for ligand-based drug design. The computational study deals with development of 3D QSAR models for 85 selected quinazoline derivatives using the stepwise variable selection knearest neighbor molecular field analysis approach; a leave-one-out cross validation method. The developed model showed satisfactory statistical significance r2 (Regression) with 0.75 and q2 (Correlation coefficient) 0.81. Further we have carried out molecular docking studies with the x-ray crystal structure of glycogen synthase kinase domain. These studies showed that quinazoline scaffold can be utilized for designing of novel GSK-3β inhibitors.
机译:糖原合酶激酶3β(GSK3β)抑制剂的发现已被证明对鉴定新型有效的gsk3β抑制剂具有挑战性。定量结构活性关系(QSAR)和对接方法变得非常有用,并且在基于配体的药物设计中广泛使用。计算研究使用逐步可变选择近邻邻域分子场分析方法开发了针对85种选择的喹唑啉衍生物的3D QSAR模型。一种省去的交叉验证方法。所开发的模型显示出令人满意的统计显着性,r2(回归)为0.75,q2(相关系数)为0.81。此外,我们已经进行了糖原合酶激酶域的X射线晶体结构的分子对接研究。这些研究表明,喹唑啉支架可用于设计新型GSK-3β抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号